Document text
Principal Investigator: Donna L. Farber
Organization: SCRIPPS RESEARCH INSTITUTE, THE
Fiscal Year: 2024
Award: $884,886
Funding agency: National Institute of Allergy and Infectious Diseases
Project Summary/Abstract
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2), has exploded into a global pandemic causing significant loss of life, pronounced economic impact and
significant long-term medical impacts which are still being characterized. Despite impressive protection afforded
by the current SARS-CoV-2 vaccines which are primarily mediated by antibody neutralization of virus, these
antibodies wane over time and new viral variants have emerged that are less susceptible toby these antibodies.
A major question is whether memory T cells afford more long-lasting protection during SARS-CoV-2 infection.
Prior studies showed that people who recovered from SARS-CoV infection from 2003 exhibited SARS-CoV-
specific memory CD8+ T cell responses in peripheral blood for up to 11 years, virus-specific antibodies were not
detectable at 6 years, and there was no cross-reactivity with MERS-CoV peptide1,2. For the current pandemic,
we are starting to learn what types of memory T and B cells form after SARS-Cov2 infection in the blood, however
we have no idea the longevity of these responses. More importantly, we know very little about the pulmonary
memory T and B cells that form in the lung after SARS-CoV-2 infection and, based on what has been
learned from other viruses, these may be the most protective memory cells needed for superior long-
term immunity to reinfection.
In this collaborative proposal between the Teijaro, Kaech and Farber labs, we bring together world-
class expertise in anti-viral immunity and lung pathogenesis, immunological memory and human immunology
to study the development and protective role of lung-resident TRM cells in SARS-CoV-2. In Aim 1, we will
study the fundamentals of SARS-CoV-2 TRM development in the lungs of hACE2-transgenic mice and
determine whether TRM are required for long- term immunity, through genetic perturbations of Tgfbr2 and
Smad4 in T cells, which are differentially required for TRM differentiation3, and the depletion of circulating
memory cells. In Aim 2, we will examine if lung TRM cells contribute to the protection afforded by mRNA
vaccines to better understand the role, if any, of memory T cells in mediating protection to SARS-CoV-2 and
notable variants of concern (VOC). Lastly, in Aim 3, we extend and complement our studies in mice to Dr.
Farber’s human donor repository to assess human memory formation following SARS-CoV-2 infection and
vaccination. We hope to answer the basic question of which types of memory T cells form after SARS-
CoV-2 infection and confer long-term protective immunity to this virus and VOCs. These studies will
provide critical information related to the quality of immunological memory that forms after SARS-CoV-
2 infection in mice and humans and will serve to guide current and future vaccine development.
Terms: <2019 novel corona virus><2019 novel coronavirus><2019-nCoV><2019-nCoV vaccine><ARDS><Acute Respiratory Distress><Acute Respiratory Distress Syndrome><Address><Adult ARDS><Adult RDS><Adult Respiratory Distress Syndrome><Age><Animal Model><Animal Models and Related Studies><Anti-viral Therapy><Antibodies><Antigenic Determinants><B blood cells><B cell><B cells><B-Cells><B-Lymphocytes><B-cell><Binding Determinants><Blood><Blood Plasma Cell><Blood Reticuloendothelial System><Body Tissues><CD8><CD8 Cell><CD8 T cells><CD8 lymphocyte><CD8+ T cell><CD8+ T-Lymphocyte><CD8-Positive Lymphocytes><CD8-Positive T-Lymphocytes><CD8B><CD8B1><CD8B1 gene><COVID crisis><COVID epidemic><COVID pandemic><COVID-19><COVID-19 crisis><COVID-19 epidemic><COVID-19 era><COVID-19 global health crisis><COVID-19 global pandemic><COVID-19 health crisis><COVID-19 immunity><COVID-19 infection><COVID-19 pandemic><COVID-19 period><COVID-19 public health crisis><COVID-19 vaccine><COVID-19 virus><COVID-19 virus infection><COVID-19 years><COVID19 infection><COVID19 virus><CV-19><Cardiovascular Diseases><Cell Body><Cells><Cessation of life><CoV-2><CoV2><Complement><Complement Proteins><Coronary Disease><Coronary heart disease><Coronaviridae><Coronaviridae Infections><Coronavirus><Coronavirus Infections><Coronavirus Infectious Disease 2019><Da Nang Lung><Death><Development><Epitopes><Exhibits><Explosion><Future><Generations><Genetic><Goals><Grant><Grippe><Herd Immunity><Human><Immune memory><Immunity><Immunologic Memory><Immunological Memory><Immunology><Infection><Influenza><Influenza Vaccines><Intramuscular><Knowledge><LCM Viruses><LCMV><LYT3><Learning><Length of Life><Life><Longevity><Lung><Lung Respiratory System><Lung infections><Lymphocytic choriomeningitis virus><MERS corona virus><MERS coronavirus><MERS virus><MERS-CoV><Mediating><Medical><Memory><Mice><Mice Mammals><Middle East Respiratory Syndrome Corona Virus><Middle East Respiratory Syndrome Coronavirus><Middle East Respiratory Syndrome Virus><Middle East Respiratory Syndrome-CoV><Middle East Respiratory Virus><Middle East Respiratory coronavirus><Middle Eastern Respiratory Syndrome Corona virus><Middle Eastern Respiratory Syndrome Coronavirus><Middle Eastern Respiratory Syndrome Virus><Middle Eastern Respiratory Syndrome-CoV><Modeling><Modern Man><Murine><Mus><Pathogenesis><Peptides><Persons><Phenotype><Physical distancing><Plasma Cells><Plasmacytes><Population><Predisposition><RNA immunization><RNA vaccination><RNA vaccine><RNA-based vaccine><Risk Factors><Role><SARS><SARS Virus><SARS corona virus><SARS corona virus 2><SARS coronavirus><SARS coronavirus disease><SARS-Associated Coronavirus><SARS-CO-V2><SARS-COVID-2><SARS-CoV><SARS-CoV disease><SARS-CoV-1><SARS-CoV-2><SARS-CoV-2 epidemic><SARS-CoV-2 global health crisis><SARS-CoV-2 global pandemic><SARS-CoV-2 immunity><SARS-CoV-2 infection><SARS-CoV-2 pandemic><SARS-CoV-2 vaccine><SARS-CoV2><SARS-CoV2 infection><SARS-Related Coronavirus><SARS-associated corona virus 2><SARS-associated coronavirus 2><SARS-coronavirus-2><SARS-coronavirus-2 epidemic><SARS-coronavirus-2 pandemic><SARS-coronavirus-2 vaccine><SARS-related corona virus 2><SARS-related coronavirus 2><SARSCoV2><Secondary to><Severe Acute Respiratory Coronavirus><Severe Acute Respiratory Coronavirus 2><Severe Acute Respiratory Distress Syndrome CoV 2><Severe Acute Respiratory Distress Syndrome Corona Virus 2><Severe Acute Respiratory Distress Syndrome Coronavirus 2><Severe Acute Respiratory Syndrome><Severe Acute Respiratory Syndrome CoV 2><Severe Acute Respiratory Syndrome CoV 2 epidemic><Severe Acute Respiratory Syndrome CoV 2 pandemic><Severe Acute Respiratory Syndrome CoV 2 vaccine><Severe Acute Respiratory Syndrome CoV disease><Severe Acute Respiratory Syndrome Virus><Severe Acute Respiratory Syndrome corona virus><Severe Acute Respiratory Syndrome coronavirus><Severe Acute Respiratory Syndrome coronavirus disease><Severe Acute Respiratory Syndrome-associated coronavirus 2><Severe Acute Respiratory Syndrome-related coronavirus 2><Severe acute respiratory syndrome associated corona virus 2><Severe acute respiratory syndrome coronavirus 2><Severe acute respiratory syndrome coronavirus 2 epidemic><Severe acute respiratory syndrome coronavirus 2 immunity><Severe acute respiratory syndrome coronavirus 2 infection><Severe acute respiratory syndrome coronavirus 2 pandemic><Severe acute respiratory syndrome coronavirus 2 vaccine><Severe acute respiratory syndrome related corona virus 2><Shock Lung><Social Distance><Societies><Stiff lung><Susceptibility><T cell response><T memory cell><T-Cells><T-Lymphocyte><T8 Cells><T8 Lymphocytes><Time><Tissues><Transgenic Mice><Vaccinated><Vaccination><Vaccines><Variant><Variation><Viral><Viral Diseases><Virus><Virus Diseases><Work><Wuhan coronavirus><after COVID-19 infection><after SARS-CoV-2 infection><after SARS-CoV2 infection><after infection by SARS-CoV-2><after severe acute respiratory distress syndrome CoV-2 infection><ages><anamnestic reaction><anti-viral immunity><antiviral immunity><atherosclerotic heart disease><cardiovascular disorder><complementation><corona virus><coronary disorder><coronavirus disease 2019><coronavirus disease 2019 crisis><coronavirus disease 2019 epidemic><coronavirus disease 2019 global health crisis><coronavirus disease 2019 global pandemic><coronavirus disease 2019 health crisis><coronavirus disease 2019 immunity><coronavirus disease 2019 infection><coronavirus disease 2019 pandemic><coronavirus disease 2019 public health crisis><coronavirus disease 2019 vaccine><coronavirus disease 2019 virus><coronavirus disease crisis><coronavirus disease epidemic><coronavirus disease pandemic><coronavirus disease-19><coronavirus disease-19 global pandemic><coronavirus disease-19 pandemic><coronavirus disease-19 vaccine><coronavirus disease-19 virus><coronavirus infectious disease-19><cross immunity><cross protection><cross reactivity><current pandemic><depository><design><designing><develop a vaccine><develop vaccines><development of a vaccine><developmental><economic impact><fighting><flu><flu infection><flu serotype><flu strain><flu subtype><flu vaccine><flu viral strain><flu virus infection><flu virus strain><flu virus vaccine><following COVID-19 infection><following SARS-CoV-2 infection><following SARS-CoV2 infection><following infection by SARS-CoV-2><following severe acute respiratory distress syndrome CoV-2 infection><hCoV19><human model><immunity against COVID-19><immunity against SARS-CoV-2><immunity against Severe acute respiratory syndrome coronavirus 2><immunity against coronavirus disease 2019><immunity to COVID-19><immunity to SARS-CoV-2><immunity to Severe acute respiratory syndrome coronavirus 2><immunity to coronavirus disease 2019><infected with COVID-19><infected with COVID19><infected with SARS-CoV-2><infected with SARS-CoV2><infected with coronavirus disease 2019><infected with flu><infected with flu virus><infected with influenza><infected with influenza virus><infected with severe acute respiratory syndrome coronavirus 2><influenza infection><influenza serotype><influenza strain><influenza subtype><influenza viral strain><influenza virus infection><influenza virus strain><influenza virus vaccine><insight><lung development><lung function><mRNA immunization><mRNA vaccination><mRNA vaccine><mRNA-based vaccine><memory T lymphocyte><model of animal><model of human><mouse model><murine model><nCoV vaccine><nCoV-19 vaccine><nCoV19 vaccine><nCoV2><neutralizing antibody><pandemic><pandemic disease><peripheral blood><plasmocyte><post SARS-CoV-2 infection><present pandemic><previous COVID-19 infection><previous SARS-CoV-2 infection><previous SARS-CoV2 infection><previous severe acute respiratory distress syndrome CoV-2 infection><prior COVID-19 infection><prior SARS-CoV-2 infection><prior SARS-CoV2 infection><prior severe acute respiratory distress syndrome CoV-2 infection><pulmonary><pulmonary function><pulmonary infections><repository><resident memory T cell><response><secondary immune response><severe acute respiratory syndrome coronavirus 2 global health crisis><severe acute respiratory syndrome coronavirus 2 global pandemic><severe acute respiratory syndrome-CoV><social role><thymus derived lymphocyte><tissue resident memory T cell><vaccine against 2019-nCov><vaccine against COVID-19><vaccine against SARS-CoV-2><vaccine against SARS-coronavirus-2><vaccine against Severe Acute Respiratory Syndrome CoV 2><vaccine against Severe acute respiratory syndrome coronavirus 2><vaccine against flu><vaccine against influenza><vaccine candidates against SARS-CoV-2><vaccine development><vaccine efficacy><vaccine for novel coronavirus><vaccines preventing COVID><vaccines to prevent COVID><variants of concern><viral infection><viral infectious disease treatment><virus infection><virus-induced disease><wet lung>